302
Views
16
CrossRef citations to date
0
Altmetric
Original Research

Avanafil for treatment of erectile dysfunction: review of its potential

&
Pages 517-523 | Published online: 29 Aug 2012

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (6)

Syah Mirsya Warli, Steven Steven, Dhirajaya Dharma Kadar, Fauriski Febrian Prapiska & Ginanda Putra Siregar. (2023) The Efficacy and Safety of Avanafil During a Treatment of Male Erectile Dysfunction: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. Therapeutics and Clinical Risk Management 19, pages 629-644.
Read now
Prasada Chowdari Gurram, Sairaj Satarker, Gautam Kumar, Farmiza Begum, Chetan Mehta, Usha Nayak, Jayesh Mudgal, Devinder Arora & Madhavan Nampoothiri. (2023) Avanafil mediated dual inhibition of IKKβ and TNFR1 in an experimental paradigm of Alzheimer’s disease: in silico and in vivo approach. Journal of Biomolecular Structure and Dynamics 41:20, pages 10659-10677.
Read now
Jonathan L. Zurawin, Carrie A. Stewart, James E. Anaissie, Faysal A. Yafi & Wayne J. G. Hellstrom. (2016) Avanafil for the treatment of erectile dysfunction. Expert Review of Clinical Pharmacology 9:9, pages 1163-1170.
Read now
Jeffery D Evans & Stephen R Hill. (2015) A comparison of the available phosphodiesterase-5 inhibitors in the treatment of erectile dysfunction: a focus on avanafil. Patient Preference and Adherence 9, pages 1159-1164.
Read now
Eric G Katz, Ronny BW Tan, Daniel Rittenberg & Wayne J Hellstrom. (2014) Avanafil for erectile dysfunction in elderly and younger adults: differential pharmacology and clinical utility. Therapeutics and Clinical Risk Management 10, pages 701-711.
Read now
Roberto Bruzziches, Davide Francomano, Pietro Gareri, Andrea Lenzi & Antonio Aversa. (2013) An update on pharmacological treatment of erectile dysfunction with phosphodiesterase type 5 inhibitors. Expert Opinion on Pharmacotherapy 14:10, pages 1333-1344.
Read now

Articles from other publishers (10)

Khalid M. El-Say, Omar D. Al-hejaili, Hossam S. El-Sawy, Nabil A. Alhakamy, Fathy I. Abd-Allah, Martin K. Safo & Tarek A. Ahmed. (2023) Incorporating sodium deoxycholate endorsed the buccal administration of avanafil to heighten the bioavailability and duration of action. Drug Delivery and Translational Research 13:9, pages 2297-2314.
Crossref
Ahmed R. Gardouh, Sameh Elhusseiny & Shadeed Gad. (2022) Mixed Avanafil and Dapoxetin Hydrochloride cyclodextrin nano-sponges: Preparation, in-vitro characterization, and bioavailability determination. Journal of Drug Delivery Science and Technology 68, pages 103100.
Crossref
Mallesh Kurakula, Raghavendra Naveen N.Bhaumik Patel, Ravi Manne & Devang B. Patel. (2021) Preparation, Optimization and Evaluation of Chitosan-Based Avanafil Nanocomplex Utilizing Antioxidants for Enhanced Neuroprotective Effect on PC12 Cells. Gels 7:3, pages 96.
Crossref
Abdullah A. Alamoudi, Osama A. A. Ahmed & Khalid M. El-Say. (2021) Investigating the Potential of Transdermal Delivery of Avanafil Using Vitamin E-TPGS Based Mixed Micelles Loaded Films. Pharmaceutics 13:5, pages 739.
Crossref
В. В. Спиридоненко. (2019) Avanafil – a New Means for Treating Erectile Dysfunction in the Ukraine Market. Health of Man:4, pages 57-62.
Crossref
Jinze Li, Lei Peng, Dehong Cao, Lujia He, Yunxiang Li & Qiang Wei. (2019) Avanafil for the Treatment of men With Erectile Dysfunction: A Systematic Review and Meta-analysis of Randomized Controlled Trials. American Journal of Men's Health 13:5, pages 155798831988076.
Crossref
Nafiz CAN. (2018) Development of Validated and Stability-Indicating LC-DAD and LC-MS/MS Methods for Determination of Avanafil in Pharmaceutical Preparations and Identification of a Novel Degradation Product by LCMS-IT-TOF. Molecules 23:7, pages 1771.
Crossref
G. Hatiboglu, I. V. Popeneciu, M. Deppert, J. Nyarangi-Dix, B. Hadaschik, M. Hohenfellner, D. Teber & S. Pahernik. (2017) Quality of life and functional outcome after infravesical desobstruction and HIFU treatment for localized prostate cancer. BMC Urology 17:1.
Crossref
Giovanni Corona, Mario Maggi & Emmanuele A. Jannini. (2016) Avanafil: The Second-Generation Treatment of Erectile Dysfunction. European Medical Journal, pages 61-69.
Crossref
Hartmut Porst. (2016) Patient Insight and Treatment Expectations in Erectile Dysfunction. European Medical Journal, pages 34-41.
Crossref